CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection

Pediatr Res. 2013 Feb;73(2):187-93. doi: 10.1038/pr.2012.163. Epub 2012 Nov 19.

Abstract

Background: Current tools to predict the severity of respiratory syncytial virus (RSV) infection might be improved by including immunological parameters. We hypothesized that a combination of inflammatory markers would differentiate between severe and mild disease in RSV-infected children.

Methods: Blood and nasopharyngeal samples from 52 RSV-infected children were collected during acute infection and after recovery. Retrospectively, patients were categorized into three groups based on disease severity: mild (no supportive treatment), moderate (supplemental oxygen and/or nasogastric feeding), and severe (mechanical ventilation). Clinical data, number of flow-defined leukocyte subsets, and cytokine concentrations were compared.

Results: Children with severe RSV infection were characterized by young age; lymphocytopenia; increased interleukin (IL)-8, granulocyte colony-stimulating factor (G-CSF), and IL-6 concentrations; and decreased chemokine (C-C motif) ligand (CCL-5) concentrations in plasma. The combination of plasma levels of IL-8 and CCL-5, and CD4+ T-cell counts, with cutoff values of 67 pg/ml, 13 ng/ml, and 2.3 × 10(6)/ml, respectively, discriminated severe from mild RSV infection with 82% sensitivity and 96% specificity.

Conclusion: This study demonstrates that the combination of CD4+ T-cell counts and IL-8 and CCL-5 plasma concentrations correlates with disease severity in RSV-infected children. In addition to clinical features, these immunological markers may be used to assess severity of RSV infection and guide clinical management.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Biomarkers / blood
  • Bronchiolitis, Viral / blood
  • Bronchiolitis, Viral / diagnosis*
  • Bronchiolitis, Viral / immunology
  • Bronchiolitis, Viral / therapy
  • Bronchiolitis, Viral / virology
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / virology
  • Chemokine CCL5 / blood*
  • Chi-Square Distribution
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Inflammation Mediators / blood*
  • Interleukin-8 / blood*
  • Male
  • Predictive Value of Tests
  • Prognosis
  • Respiratory Syncytial Virus Infections / blood
  • Respiratory Syncytial Virus Infections / diagnosis*
  • Respiratory Syncytial Virus Infections / immunology
  • Respiratory Syncytial Virus Infections / therapy
  • Respiratory Syncytial Virus Infections / virology
  • Respiratory Syncytial Virus, Human / immunology*
  • Retrospective Studies
  • Severity of Illness Index
  • Viral Load

Substances

  • Biomarkers
  • CCL5 protein, human
  • CXCL8 protein, human
  • Chemokine CCL5
  • Inflammation Mediators
  • Interleukin-8